52 related articles for article (PubMed ID: 17438071)
1. High-throughput screening for norepinephrine transporter inhibitors using the FLIPRTetra.
Wagstaff R; Hedrick M; Fan J; Crowe PD; DiSepio D
J Biomol Screen; 2007 Apr; 12(3):436-41. PubMed ID: 17438071
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of a fluorescent uptake assay for the noradrenaline transporter.
Haunsø A; Buchanan D
J Biomol Screen; 2007 Apr; 12(3):378-84. PubMed ID: 17379857
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and pharmacological evaluation of phenoxy pyridyl derivatives as dual norepinephrine reuptake inhibitors and 5-HT1A partial agonists.
Dounay AB; Barta NS; Campbell BM; Coleman C; Collantes EM; Denny L; Dutta S; Gray DL; Hou D; Iyer R; Maiti SN; Ortwine DF; Probert A; Stratman NC; Subedi R; Whisman T; Xu W; Zoski K
Bioorg Med Chem Lett; 2010 Feb; 20(3):1114-7. PubMed ID: 20031410
[TBL] [Abstract][Full Text] [Related]
4. Validation of a fluorescence-based high-throughput assay for the measurement of neurotransmitter transporter uptake activity.
Jørgensen S; Nielsen EØ; Peters D; Dyhring T
J Neurosci Methods; 2008 Mar; 169(1):168-76. PubMed ID: 18222006
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships of chiral selective norepinephrine reuptake inhibitors (sNRI) with increased oxidative stability.
Hudson S; Kiankarimi M; Eccles W; Dwight W; Mostofi YS; Genicot MJ; Fleck BA; Gogas K; Aparicio A; Wang H; Wen J; Wade WS
Bioorg Med Chem Lett; 2008 Aug; 18(16):4491-4. PubMed ID: 18672364
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a potent, selective, and less flexible selective norepinephrine reuptake inhibitor (sNRI).
Wu D; Pontillo J; Ching B; Hudson S; Gao Y; Fleck BA; Gogas K; Wade WS
Bioorg Med Chem Lett; 2008 Jul; 18(14):4224-7. PubMed ID: 18550369
[TBL] [Abstract][Full Text] [Related]
7. Influence of ligand binding kinetics on functional inhibition of human recombinant serotonin and norepinephrine transporters.
Tsuruda PR; Yung J; Martin WJ; Chang R; Mai N; Smith JA
J Pharmacol Toxicol Methods; 2010; 61(2):192-204. PubMed ID: 20036748
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores.
Fensome A; Goldberg J; McComas CC; Trybulski EJ; Woodworth RP; Deecher DC; Whiteside GT; Zhang P
Bioorg Med Chem Lett; 2010 Mar; 20(5):1555-8. PubMed ID: 20153188
[TBL] [Abstract][Full Text] [Related]
9. Binding and transport in norepinephrine transporters. Real-time, spatially resolved analysis in single cells using a fluorescent substrate.
Schwartz JW; Blakely RD; DeFelice LJ
J Biol Chem; 2003 Mar; 278(11):9768-77. PubMed ID: 12499385
[TBL] [Abstract][Full Text] [Related]
10. Monoamine transporter inhibitors and norepinephrine reduce dopamine-dependent iron toxicity in cells derived from the substantia nigra.
Paris I; Martinez-Alvarado P; Perez-Pastene C; Vieira MN; Olea-Azar C; Raisman-Vozari R; Cardenas S; Graumann R; Caviedes P; Segura-Aguilar J
J Neurochem; 2005 Mar; 92(5):1021-32. PubMed ID: 15715653
[TBL] [Abstract][Full Text] [Related]
11. Molecular microfluorometry: converting arbitrary fluorescence units into absolute molecular concentrations to study binding kinetics and stoichiometry in transporters.
Schwartz JW; Piston D; DeFelice LJ
Handb Exp Pharmacol; 2006; (175):23-57. PubMed ID: 16722229
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a new series of monoamine reuptake inhibitors, the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ols.
Kim CY; Mahaney PE; McConnell O; Zhang Y; Manas E; Ho DM; Deecher DC; Trybulski EJ
Bioorg Med Chem Lett; 2009 Sep; 19(17):5029-32. PubMed ID: 19632110
[TBL] [Abstract][Full Text] [Related]
13. Vicinal disulfide constrained cyclic peptidomimetics: a turn mimetic scaffold targeting the norepinephrine transporter.
Brust A; Wang CI; Daly NL; Kennerley J; Sadeghi M; Christie MJ; Lewis RJ; Mobli M; Alewood PF
Angew Chem Int Ed Engl; 2013 Nov; 52(46):12020-3. PubMed ID: 24115503
[No Abstract] [Full Text] [Related]
14. An offline-addition format for identifying GPCR modulators by screening 384-well mixed compounds in the FLIPR.
Gopalakrishnan SM; Mammen B; Schmidt M; Otterstaetter B; Amberg W; Wernet W; Kofron JL; Burns DJ; Warrior U
J Biomol Screen; 2005 Feb; 10(1):46-55. PubMed ID: 15695343
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of nonexocytotic norepinephrine release by desipramine reduces myocardial infarction size.
Richardt D; Dendorfer A; Tölg R; Dominiak P; Richardt G
Can J Physiol Pharmacol; 2006 Nov; 84(11):1185-9. PubMed ID: 17218983
[TBL] [Abstract][Full Text] [Related]
16. Combinatorial synthesis of benztropine libraries and their evaluation as monoamine transporter inhibitors.
Pedersen H; Sinning S; Bulow A; Wiborg O; Falborg L; Bols M
Org Biomol Chem; 2004 Oct; 2(19):2861-9. PubMed ID: 15455161
[TBL] [Abstract][Full Text] [Related]
17. A cell-based assay for screening lipoxygenase inhibitors.
Nair DG; Funk CD
Prostaglandins Other Lipid Mediat; 2009 Dec; 90(3-4):98-104. PubMed ID: 19804839
[TBL] [Abstract][Full Text] [Related]
18. High-throughput screening for Kv1.3 channel blockers using an improved FLIPR-based membrane-potential assay.
Liu K; Samuel M; Tillett J; Hennan JK; Mekonnen B; Soloveva V; Harrison RK; Paslay JW; Larocque J
J Biomol Screen; 2010 Feb; 15(2):185-95. PubMed ID: 20044579
[TBL] [Abstract][Full Text] [Related]
19. Further structural exploration of trisubstituted asymmetric pyran derivatives (2S,4R,5R)-2-benzhydryl-5-benzylamino-tetrahydropyran-4-ol and their corresponding disubstituted (3S,6S) pyran derivatives: a proposed pharmacophore model for high-affinity interaction with the dopamine, serotonin, and norepinephrine transporters.
Zhang S; Fernandez F; Hazeldine S; Deschamps J; Zhen J; Reith ME; Dutta AK
J Med Chem; 2006 Jul; 49(14):4239-47. PubMed ID: 16821783
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes.
Kotturi SV; Jiang S; Chang AC; Abraham P; Navarro HA; Kuhar MJ; Carroll FI
J Med Chem; 2005 Nov; 48(23):7437-44. PubMed ID: 16279803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
